Literature DB >> 25427584

ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.

Zheng-Yuan Xie1, Ke Lv, Ying Xiong, Wu-Hua Guo.   

Abstract

BACKGROUND: Recent studies have reported that the presence of cancer stem cells (CSCs) has major implications in the treatment of cancer and is responsible for tumor relapse. In the current study, we identified and characterized colon CSC-like side population (SP) cells from colon cancer tissue.
MATERIALS AND METHODS: The colon cancer samples were subjected to fluorescence-activated cell sorting (FACS) based on Hoechst 33342 dye exclusion for the purification of SP cells. The sorted SP cells were subjected to further characterization by immunofluorescence, real-time polymerase chain reaction (RT-PCR), multidrug resistance, and sphere formation assays.
RESULTS: We identified a fraction of 3.3% of SP cells in the colon cancer cell samples, which was reduced to 0.6% upon treatment with verapamil. The sorted SP cells showed high positivity with regard to CD133, CD44, CD147, and EpCAM, by fluorescence microscopic analysis. Further, these SP cells were highly resistant to multidrug treatment due to overexpression of the multidrug resistance 1 (MDR1) transporter protein ABCG2.
CONCLUSION: Our findings suggest that the overexpression of ABCG2 and the expression of stem cell surface markers are collectively responsible for chemotherapy failure, tumor recurrence, and invasion in colon cancer.
© 2014 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25427584     DOI: 10.1159/000368842

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  22 in total

Review 1.  Therapeutic targeting of gastrointestinal cancer stem cells.

Authors:  Jonathan Stem; John C Flickinger; Dante Merlino; Ellen M Caparosa; Adam E Snook; Scott A Waldman
Journal:  Regen Med       Date:  2019-04-26       Impact factor: 3.806

2.  Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.

Authors:  Ning Ji; Yuqi Yang; Chao-Yun Cai; Zi-Ning Lei; Jing-Quan Wang; Pranav Gupta; Suneet Shukla; Suresh V Ambudkar; Dexin Kong; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2018-10-10       Impact factor: 8.679

3.  Combined effects of octreotide and cisplatin on the proliferation of side population cells from anaplastic thyroid cancer cell lines.

Authors:  Zhilan Li; Xiudi Jiang; Peihong Chen; Xuebing Wu; Aihua Duan; Yiyu Qin
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

Review 4.  Resistance to Cell Death and Its Modulation in Cancer Stem Cells.

Authors:  Ahmad R Safa
Journal:  Crit Rev Oncog       Date:  2016

Review 5.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

6.  Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Authors:  Li Wang; JianTao Wang; Zhixi Li; YanYang Liu; Ming Jiang; Yan Li; Dan Cao; Maoyuan Zhao; Feng Wang; Feng Luo
Journal:  Tumour Biol       Date:  2015-12-14

Review 7.  Reporters of Cancer Stem Cells as a Tool for Drug Discovery.

Authors:  Amrutha Mohan; Reshma Raj R; Gayathri Mohan; Padmaja K P; Tessy Thomas Maliekal
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

8.  Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma.

Authors:  Xian Lin; Baocun Sun; Dongwang Zhu; Xiulan Zhao; Ran Sun; Yanhui Zhang; Danfang Zhang; Xueyi Dong; Qiang Gu; Yanlei Li; Fang Liu
Journal:  Cancer Sci       Date:  2016-06-28       Impact factor: 6.716

Review 9.  Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells.

Authors:  Amrutha Mohan; Reshma Raj Rajan; Gayathri Mohan; Padmaja Kollenchery Puthenveettil; Tessy Thomas Maliekal
Journal:  Front Cell Dev Biol       Date:  2021-06-03

10.  Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.

Authors:  Jin-Yong Zhou; Min Chen; Long Ma; Xiaoxiao Wang; Yu-Gen Chen; Shen-Lin Liu
Journal:  Oncotarget       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.